American Century Companies Inc Icosavax, Inc. Transaction History

American Century Companies Inc

  • $160 Billion
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024
BUY
$5.95 - $15.79 $153,420 - $407,145
25,785 New
25,785 $406,000
Q3 2023

Nov 13, 2023
BUY
$7.22 - $10.05 $115,346 - $160,558
15,976 New
15,976 $123,000

Others Institutions Holding ICVX

# of Institutions
2
Shares Held
1.37M
Call Options Held
0
Put Options Held
0
View Full List

About Icosavax, Inc.

ICVX Quotes by TradingView
  • Ticker ICVX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,885,200
  • Description
  • Icosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases. The company, with the help of its virus-like particle (VLP) platform technology, focuses primarily on life-threatening respiratory diseases. Its products in pipeline include IVX-121, a vaccine candidate with RSV target and is under Phase 1/1b clinical tri...
More about ICVX
Track This Portfolio

Track American Century Companies Inc Portfolio

Follow American Century Companies Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email